Monday, December 23, 2024
HomeTagsGO Therapeutics

GO Therapeutics

Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology

Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO") announced that Xyphos Biosciences,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics